
2.5 Lu clock (GrimAge Clock)
mune function, which often declines with age. By
integrating this broader range of data points, DNAm
PhenoAge strives to provide a more holistic and nu-
anced assessment of biological age.
Studies suggest that DNAm PhenoAge offers su-
perior accuracy compared to its predecessors in pre-
dicting various age-related outcomes. This includes
mortality risk, an individual’s physical capabilities, and
even healthspan, which refers to the duration of good
health in a person’s life. These advancements hold
promise for several potential applications. In personal-
ized medicine, doctors could leverage this information
to tailor preventive healthcare strategies based on an
individual’s biological age in relation to their chrono-
logical age. Researchers could also utilize DNAm Phe-
noAge in clinical trials to assess the effectiveness of
anti-aging therapies by monitoring changes in biolog-
ical age. Furthermore, this clock can contribute sig-
nificantly to a deeper understanding of the biological
processes underlying aging itself.
While DNAm PhenoAge stands out for its com-
prehensiveness, it’s important to acknowledge limita-
tions. The technology used to analyze the combined
data points might be more expensive and less readily
available compared to simpler clocks. Additionally,
like other epigenetic clocks, DNAm PhenoAge is pri-
marily optimized for blood samples. Its accuracy in
other tissues needs further investigation.
2.5 Lu clock (GrimAge Clock)
The GrimAge Clock, also known as the Lu clock,
is an epigenetic clock developed by Steve Horvath in
collaboration with Daniel W. Belsky, Ian Deary, and
others. It was introduced in 2019 as an advancement
in the field of epigenetic aging research.
The GrimAge Clock is notable for its focus on
age-related mortality risk and its incorporation of DNA
methylation-based biomarkers associated with various
age-related health outcomes. Unlike other epigenetic
clocks that primarily estimate chronological age, the
GrimAge Clock aims to estimate biological age with
a particular emphasis on predicting mortality risk and
age-related diseases.
The development of the GrimAge Clock involved
the identification of DNA methylation patterns associ-
ated not only with chronological age but also with mor-
tality risk and various age-related health conditions,
such as cardiovascular disease, cancer, and Alzheimer’s
disease. This was achieved by analyzing large-scale
DNA methylation datasets from diverse populations.
The GrimAge Clock is unique in that it incor-
porates DNA methylation-based biomarkers known as
”epigenetic aging signatures” that are associated with
smoking behavior, inflammation, and other factors im-
plicated in aging-related processes. By including these
additional biomarkers, the GrimAge Clock provides a
more comprehensive assessment of biological age and
mortality risk compared to other epigenetic clocks.
2.6 Conclusion
In conclusion, the field of epigenetic clocks has
emerged as a powerful tool for understanding biological
aging. Pioneering clocks like the Horvarth clock and
Hannum clock (2013) laid the groundwork by analyz-
ing DNA methylation patterns to estimate biological
age. The Weidner clock (2014) followed, offering a
simpler yet accurate approach. Building upon these,
DNAm PhenoAge (Levin clock, 2015) incorporated
additional factors like chronological age and blood test
results for a more comprehensive assessment. Finally,
the GrimAge clock (2018) stands out for its unique fo-
cus on predicting mortality risk based on specific DNA
methylation patterns.
Despite their differences, these clocks all offer
valuable insights into the biological aging process.
They hold promise for personalized medicine approaches
that consider an individual’s biological age, potentially
leading to more targeted preventive healthcare strate-
gies and interventions. As research progresses, epi-
genetic clocks like the Lu DNAmTL clock, exploring
specific aspects of aging like telomere function, might
further refine our understanding of how our bodies age
at a cellular level. While limitations exist, particularly
regarding tissue specificity and the influence of fac-
tors beyond aging, epigenetic clocks represent a sig-
nificant leap forward in the fight against age-related
25